GRIDD is a world-class research facility, offering unique resources and drawing on a global network of partners to target the world’s most devastating diseases.

GRIDD is a Griffith University research institute with a focus on early stage and pre-clinical drug discovery. GRIDD’s aim is to utilise its unique resources, dedicated researchers and international partnerships to drive the discovery and development of revolutionary new treatments to improve human health and wellbeing.

We are currently focusing on a number of key discovery areas, including cancer, infectious diseases, Parkinson’s disease, drug resistance and spinal cord injury repair. Innovating at the cutting-edge of both chemistry and biology, we have ongoing established partnerships where we collaborate with local and national health institutions, governments, academia, industry, not-for-profit organisations and communities to create knowledge that transforms lives.

GRIDD is home to two significant resources in Compounds Australia and NatureBank. Compounds Australia is the nations’ industry standard compound curation facility, unmatched in the Southern hemisphere and a leader globally. NatureBank is Australia’s largest collection of raw biota, processed into large extract and fraction libraries. Both resources are available to researchers and industry worldwide that, like GRIDD, are seeking to discover new treatments and cures for debilitating illnesses.